Oppenheimer analyst Michael Wiederhorn is updating its Amedisys (AMED) model following the Q4 earnings release. Amedisys is currently in the ...

Amedisys’ AMED continuously improving clinical quality for patients, demonstrated through high Quality of Patient Care and Patient Satisfaction star ratings, is poised to drive growth in the upcoming ...

Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry. Amedisys, for the fourth quarter of ...

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported a fourth-quarter loss of $20.4 million, after reporting a profit in the same period a year earlier.

(2) Adjusted EBITDA is defined as net (loss) income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain ...

Amedisys shares have risen nearly 1% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $91.57, a fall of roughly 3% in the last 12 months.